Changing paradigms in spondylarthritis: the myofibroblast signature

Arthritis Rheum. 2013 Jan;65(1):24-7. doi: 10.1002/art.37703.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antirheumatic Agents / therapeutic use*
  • Humans
  • Spondylitis, Ankylosing / drug therapy*
  • Spondylitis, Ankylosing / pathology*

Substances

  • Antirheumatic Agents